Status:
UNKNOWN
Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Caregivers
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
Use lay language. The Covid-19 pandemic hit France in March 2020 and stage 3 of the epidemic justified the introduction of national and unprecedented containment measures from March 17, 2020. The Mont...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- exposed group: exposed caregivers and agents who worked in COVID units (medicine, resuscitation, screening) until their date of collection. An exposed agent or caregiver is defined by the entrance of rooms with a COVID-19 infection during their professional activity.
- low or unexposed group: caregivers or agents who have worked in non-COVID units in a non-COVID hospital
- Exclusion criteria:
- \- refusal to participate
Exclusion
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04376944
Start Date
April 1 2020
End Date
December 30 2020
Last Update
May 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uh Montpellier
Montpellier, France, 34295